Email this page to a friend. Bookmark this page.Print this page.

  • Home Page
  • Case Studies
    • Pressure Ulcers
      • Pressure Ulcers
      • Pressure Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
      • Diabetic Foot Ulcers
    • Surgical Wounds
      • Mohs Surgery
      • Wound Dehiscence
      • Mohs Surgery
    • Venous Ulcers
  • About Excellagen
  • News
  • Publications and Meetings
  • Science - How Does Formulated Collagen Work
  • FAQ
  • Physician Information
  • Product Literature
  • Partnering
    • AvKARE
  • Distributor Opportunities
  • Contact Us


Information for Health Care Professionals



May 12, 2014 - Taxus Cardium’s Excellagen Selected for Use with Stem Cells in EU-Funded Human Clinical Study

December 4, 2013 - Cardium’s Excellagen Assigned Q Code For Product Reimbursement

August 7, 2013 - Cardium Announces Excellagen Distribution Agreement with Kasiak for Germany and Switzerland

August 6, 2013 - Cardium Reports on New Excellagen-Based Stromal Cell Research for Wound Healing with Orbsen Therapeutics under European FP7 Reddstar Diabetes Initiative

August 5, 2013 - Cardium Announces New Excellagen FDA 510(k) Submission Based on Expanded Structural and Functional Properties

August 1, 2013 - Cardium Reports on New Excellagen Distribution Agreement witeh AvKARE for Veterans Hospitals and Other Government Medical Facilities

April 30, 2013 - Cardium Announces Excellagen® Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting

March 14, 2013 - Cardium Receives ISO Certification for Excellagen®

February 12, 2013 - Cardium's Excellagen® Awarded American Podiatric Medical Association Seal of Approval

January 3, 2013 - Cardium Announces Sales and Distribution Agreement with Academy Medical to Promote Excellagen Clinical Adoption by U.S. Government Medical Providers

November 13, 2012 - Cardium Announces Excellagen Poster Presentations at Desert Foot 9th Annual High Risk Diabetic Foot Conference

September 20, 2012 - Cardium Announces Medical Advisory Board to Support Excellagen® Advanced Wound Care Product

August 1, 2012 - Cardium's Excellagen® Named as Top 10 Innovation in Podiatry

June 12, 2012 - Cardium Announces Plan for Commercialization of Excellagen® in the Russian Federation

June 5, 2012 - AMRI Burlington Contracted As Aseptic Fill Manufacturer for Market Introduction of Excellagen® Wound Care Product

March 30, 2012 - Cardium Announces U.S. Market Introduction of Excellagen™

January 5, 2012 - Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea

October 10, 2011 - Cardium Announces FDA 501(k) Clearance for U.S. Marketing and Sale of Excellagen Formulated Collagen Topical Gel for Diabetic Foot Ulcers, Pressure Ulcers and Other Dermal Wounds

I would like to know
more about Excellagen.